Judson IR - Search Results

1

Susceptibility of fibromatosis cells in short-term culture to Ifosfamide: a possible experimental treatment in clinically aggressive cases.

Verrill MW, Coley HM, Judson IR, Fisher C. Verrill MW, et al. Among authors: judson ir. Sarcoma. 1999;3(2):79-84. doi: 10.1080/13577149977686. Sarcoma. 1999. PMID: 18521267 Free PMC article.

2

In vitro and in vivo antitumor activity of benzyl isothiocyanate: a natural product from Tropaeolum majus.

Pintão AM, Pais MS, Coley H, Kelland LR, Judson IR. Pintão AM, et al. Among authors: judson ir. Planta Med. 1995 Jun;61(3):233-6. doi: 10.1055/s-2006-958062. Planta Med. 1995. PMID: 7617765

3

The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studies.

Coley HM, Brooks N, Phillips DH, Hewer A, Jenkins TC, Jarman M, Judson IR. Coley HM, et al. Among authors: judson ir. Biochem Pharmacol. 1995 May 11;49(9):1203-12. doi: 10.1016/0006-2952(95)00040-7. Biochem Pharmacol. 1995. PMID: 7763301

4

Stable analogues of the antitumour agent trimelamol retain in vitro cytotoxicity in drug-sensitive and resistant rodent and human cell lines.

Coley HM, Jarman M, Brooks N, Thornton TJ, Judson IR. Coley HM, et al. Among authors: judson ir. Eur J Cancer. 1994;30A(12):1827-36. doi: 10.1016/0959-8049(94)00323-w. Eur J Cancer. 1994. PMID: 7880614

5

Synthesis and cytotoxicity of potential tumor-inhibitory analogues of trimelamol (2,4,6-tris[(hydroxymethyl)methylamino]-1,3,5-triazine) having electron-withdrawing groups in place of methyl.

Jarman M, Coley HM, Judson IR, Thornton TJ, Wilman DE, Abel G, Rutty CJ. Jarman M, et al. Among authors: judson ir. J Med Chem. 1993 Dec 24;36(26):4195-200. doi: 10.1021/jm00078a008. J Med Chem. 1993. PMID: 8277501

6

The activity of N-(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenografts.

Coley HM, Jarman M, Jones M, Sargent JM, Kubota T, Lee NC, Goddard PM, Elgie AW, Williamson C, Taylor CG, Judson IR. Coley HM, et al. Among authors: judson ir. Anticancer Res. 1996 Jul-Aug;16(4A):1851-5. Anticancer Res. 1996. PMID: 8712712

7

Pre-clinical development of the anti-tumour agent CB 7646, bis N-(hydroxymethyl) trimethylmelamine, a stable analogue of trimelamol.

Coley HM, Jarman M, Brooks N, Kubota T, Goddard PM, Jones M, Lee N, Owens MD, Halbert GW, Judson IR. Coley HM, et al. Among authors: judson ir. Int J Cancer. 1996 Nov 4;68(3):356-63. doi: 10.1002/(SICI)1097-0215(19961104)68:3<356::AID-IJC14>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8903478

8

Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children?

Verrill MW, Judson IR, Harmer CL, Fisher C, Thomas JM, Wiltshaw E. Verrill MW, et al. Among authors: judson ir. J Clin Oncol. 1997 Jul;15(7):2611-21. doi: 10.1200/JCO.1997.15.7.2611. J Clin Oncol. 1997. PMID: 9215832

9

The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours.

Verrill MW, Judson IR, Wiltshaw E, Thomas JM, Harmer CL, Fisher C. Verrill MW, et al. Among authors: judson ir. Ann Oncol. 1997 Nov;8(11):1099-105. doi: 10.1023/a:1008264902857. Ann Oncol. 1997. PMID: 9426329 Free article.

10

Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.

Coley HM, Verrill MW, Gregson SE, Odell DE, Fisher C, Judson IR. Coley HM, et al. Among authors: judson ir. Eur J Cancer. 2000 May;36(7):881-8. doi: 10.1016/s0959-8049(00)00032-0. Eur J Cancer. 2000. PMID: 10785593

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters